Faculty Information   
   日本語 >>
  1. TOP page
    2. >
  2. Clinical Medicine Seminars

Journal
Presentation
    （Last updated : 2022-11-16 10:59:02）
  Mikami Koji
   Department   Specialty Division  , Clinical Medicine Seminars
   Specialty Division  Thoracic Oncology, Clinical Medicine Seminars
   Position  
■ Journal
1. Original article　 Serum HMGB1 as a prognostic marker for malignant pleural mesothelioma. 2013/09
2. Original article　 Clinical significance of serum angiopoietin-1 in malignant peritoneal mesothelioma. 2013/10
3. Original article　 Recurrence of Lung Adenocarcinoma After an Interval of 15 Years Revealed by Demonstration of the Same Type of EML4-ALK Fusion Gene 2014/08
4. Original article　 Naftopidil Is Useful for the Treatment of Malignant Pleural Mesothelioma 2014/10
5. Introduction　 Challenges for the development of immunotherapy in small-cell lung cancer. 2018/06 Link
6. Case report　 Double cancer comprising malignant pleural mesothelioma and squamous cell carcinoma of the lung treated with radiotherapy: A case report. 2018/08 Link
7. Original article　 Early-stage Clinical Characterization of Malignant Pleural Mesothelioma. 2018/09 Link
Display 5 items
Display all(7)
■ Presentation
1. AMP Converted from Intracelluarly transported adenosine upregulates p53 expression to induce malignant pleural mesothelioma cell apoptosis  2013/10/29
2. Clinical role of pleural effusion ADA levels in malignant pleural mesothelioma  2014/10/22
3. Postoperative chemotherapy after pleurectomy/decortication for malignant pleural mesothelioma  2014/10/22
4. Naftopidil Is Effective in the Treatment of Malignant Pleural Mesothelioma.  2015/09/09
5. NF2 mutations in malignant pleural mesothelioma synchronous with acoustic neuroma:disease-causing mutation or chance effect?  2015/09/09
6. A report on three cases of intramuscular metastasis from malignant pleural mesothelioma  2015/12/20
7. Examination of the serum soluble mesothelin-related peptide (SMRP) level in patients with malignant pleural mesothelioma  2016/05/02
8. Patterns of Detectable Tumor Progression in Patients with Malignant Pleural Mesothelioma with an FDG-PET-Negative T1a Tumor  2016/05/02
9. Relationship between Histological Type and Pleural Mesothelioma  2016/05/02
10. PET/CT FOR PATIENTS WITH VERY EARLY CLINICAL STAGE OF MALIGNANT PLEURAL MESOTHELIOMA:WHEN CAT PET/CT DETECT TUMOR GROWTH OF TO/T1A MESOTHLIOMA?  2016/12/06
11. between the stainability of the neurofibromatosis type 2 gene-related protein merlin and the tumor properties of mesotheliomas  2016/12/07
12. Mesothelium Covering Pleural Plaque Is Not Primary Involved in Asbestos-Induced Mesothelial Carcinogenesis in Human  2016/12/07
13. Cisplatin in Combination for Pemetrexed in the Treatment of Patients with Advanced Malignant Peritoneal Mesothelioma -Retrospective study of 24 cases  2016/12/16
14. Prognostic Value of Changes in Neutrophil-To-Lymphocyte Ratio in Patients with Lung Cancer Treated with Nivolumab  2018/09/24
Display 5 items
Display all(14)
mail